11h data presented at the ISAM World Congress

Written By Tithi

An accepted abstract highlighted the program’s potential in substance use disorders.

Tithi
Previous

2024: Fannin Innovation Studio Accepted Into NIDA's Medications Discovery Program
Next

2021: NIH Awards Goldenrod Therapeutics $350,000 to Develop Novel Treatment for Opioid Use Disorder